Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moritz Klawitter

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|September 6, 2019
Immunoproteasome Inhibition Selectively Kills Human CD14<sup>+</sup> Monocytes and as a Result Dampens IL-23 SecretionMichael Basler, Meike Claus, Moritz Klawitter, et al.
Cancers|October 28, 2023
Intranasal Delivery of Oncolytic Adenovirus XVir-N-31 via Optimized Shuttle Cells Significantly Extends Survival of Glioblastoma-Bearing MiceAli El-Ayoubi, Moritz Klawitter, Jakob Rüttinger, et al.
European Journal of Immunology|March 8, 2024
Katharina Inholz, Janet L Anderl, Moritz Klawitter, et al.
Molecular Oncology|December 20, 2023
Development of an optimized, non-stem cell line for intranasal delivery of therapeutic cargo to the central nervous systemAli El-Ayoubi, Arsen Arakelyan, Moritz Klawitter, et al.
International Journal of Molecular Sciences|September 9, 2022
The Oncolytic Adenovirus XVir-N-31, in Combination with the Blockade of the PD-1/PD-L1 Axis, Conveys Abscopal Effects in a Humanized Glioblastoma Mouse ModelMoritz Klawitter, Ali El-Ayoubi, Jasmin Buch, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Immunology (Baltimore, Md. : 1950)|September 6, 2019
Immunoproteasome Inhibition Selectively Kills Human CD14<sup>+</sup> Monocytes and as a Result Dampens IL-23 SecretionMichael Basler, Meike Claus, Moritz Klawitter, et al.
Cancers|October 28, 2023
Intranasal Delivery of Oncolytic Adenovirus XVir-N-31 via Optimized Shuttle Cells Significantly Extends Survival of Glioblastoma-Bearing MiceAli El-Ayoubi, Moritz Klawitter, Jakob Rüttinger, et al.
European Journal of Immunology|March 8, 2024
Katharina Inholz, Janet L Anderl, Moritz Klawitter, et al.
Molecular Oncology|December 20, 2023
Development of an optimized, non-stem cell line for intranasal delivery of therapeutic cargo to the central nervous systemAli El-Ayoubi, Arsen Arakelyan, Moritz Klawitter, et al.
International Journal of Molecular Sciences|September 9, 2022
The Oncolytic Adenovirus XVir-N-31, in Combination with the Blockade of the PD-1/PD-L1 Axis, Conveys Abscopal Effects in a Humanized Glioblastoma Mouse ModelMoritz Klawitter, Ali El-Ayoubi, Jasmin Buch, et al.
Pageof 1